StemJournal (STJ), published by IOS Press, has announced the appointment of Dr. Giorgia Quadrato as the new co-Editor-in-Chief, effective immediately. Dr. Quadrato joins co-Editor-in-Chief Niels Geijsen, and an eminent international editorial board, who are dedicated to the success of the world’s international journal in stem cell research and therapy, and part of IOS Press’ StemHub.
An outstanding scientist and researcher, Giorgia Quadrato, is an Assistant Professor of Stem Cell Biology and Regenerative Medicine at the Keck School of Medicine of USC, Health Sciences Campus in Los Angeles, California. Dr. Quadrato’s research focuses on understanding the cellular and molecular basis of human brain development and disease. By combining the use of emerging models of the human brain with single cell omics approaches, she heads a research team focused on identifying cell type-specific disease mechanisms and, above all, new treatments for human neurodevelopmental disorders.
Dr. Quadrato’s appointment follows the departure of STJ’s founding editor, Dr. Chad Cowan, who has moved out of academia and is now founder and CEO of Clade Therapeutics. Dr. Cowan served as co-Editor-in-Chief for three years, from its founding and early days as a fledging journal.
StemJournal is an international, multidisciplinary, open access forum for communicating outstanding stem cell research, including basic biology, clinical applications, disease modeling, computational and systems biology, and data science. One of its primary aims is to lower the barrier to publishing truly integrative biomedical research on stem cells. Its content includes research reports, review articles, and protocols.
Click here to read the original press release.
